• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC NEUROMODULATION CORPORATION SUPERION INDIRECT DECOMPRESSION SYSTEM; PROSTHESIS, SPINOUS PROCESS SPACER/PLATE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC NEUROMODULATION CORPORATION SUPERION INDIRECT DECOMPRESSION SYSTEM; PROSTHESIS, SPINOUS PROCESS SPACER/PLATE Back to Search Results
Model Number 101-9814
Medical Device Problem Codes Material Twisted/Bent (2981); Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 02/27/2025
Type of Reportable Event Malfunction
Event or Problem Description
Device analysis performed on the returned superion indirect decompression spacer revealed that a cam-lobe was significantly bent, and a severe abrasion was observed on the mating surface of the actuator.This damage suggests that the user exerted excessive force while attempting to deploy the implant against a rigid obstruction such as a spinous process.A labeling review was conducted and revealed no anomalies.The instructions for use (ifu) specify that deployment should never be forced, as doing so may result in implant breakage or damage to surrounding bony structures.If resistance is encountered during deployment or if the device is positioned suboptimally, the implant should be completely closed before repositioning and redeploying.Additionally, the ifu cautions against attempting to adjust the device position by gear-shifting the inserter (i.E., gross cranial, caudal, or lateral articulation).The mechanical leverage provided by the inserter length may be sufficient to damage the implant or adjacent anatomy.Excessive stress on instrumentation should also be avoided.If resistance occurs during deployment of the superion implant, it may indicate interference between the implant and bony anatomy, such as the lamina or a hypertrophic spinous process, or suggest suboptimal implant positioning.
 
Additional Manufacturer Narrative
A retroactive review of events within the quality system identified this record as requiring remediation, including reporting and submission of an initial emdr per applicable criteria.Boston scientific has opened a corrective and preventive action (capa 8647) investigation to determine the root cause for why an initial emdr was not previously submitted to the fda in accordance with boston scientific established mdr reporting process and fda adverse event reporting requirements.Information gained through these investigation efforts will be utilized to determine root cause and implement appropriate preventive action(s), as necessary.
 
Event or Problem Description
Device analysis performed on the returned superion indirect decompression spacer revealed that a cam-lobe was significantly bent, and a severe abrasion was observed on the mating surface of the actuator.This damage suggests that the user exerted excessive force while attempting to deploy the implant against a rigid obstruction such as a spinous process.Additionally, a labeling review was completed and revealed no anomalies.The instructions for use (ifu) states deployment should not be forced or implant breakage or damage to bony structures may result.Furthermore, it states that if resistance to deployment is encountered, and repositioning of the implant is required, rotate the driver counterclockwise until a positive stop is reached and withdraw dorsally to collapse the cam lobes.
 
Additional Manufacturer Narrative
Correction to the initial mdr in block b5.A retroactive review of events within the quality system identified this record as requiring remediation, including reporting and submission of an initial emdr per applicable criteria.Boston scientific has opened a corrective and preventive action (capa 8647) investigation to determine the root cause for why an initial emdr was not previously submitted to the fda in accordance with boston scientific established mdr reporting process and fda adverse event reporting requirements.Information gained through these investigation efforts will be utilized to determine root cause and implement appropriate preventive action(s), as necessary.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPERION INDIRECT DECOMPRESSION SYSTEM
Common Device Name
PROSTHESIS, SPINOUS PROCESS SPACER/PLATE
Manufacturer (Section D)
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
25155 rye canyon loop
valencia CA 91355
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
erik sherburne
25155 rye canyon loop
valencia, CA 91355
7632920920
MDR Report Key23432623
Report Number3006630150-2025-09835
Device Sequence Number8870141
Product Code NQO
UDI-Device Identifier00884662000550
UDI-Public(01)00884662000550(17)280911(10)40106796
Combination Product (Y/N)N
Initial Reporter StateID
Initial Reporter CountryUS
PMA/510(K) Number
P140004
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Remedial Action Notification
Type of Report Initial,Followup
Report Date (Section B) 11/06/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number101-9814
Device Catalogue Number101-9814
Device Lot Number40106796
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/10/2025
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/21/2025
Supplement Date Received by Manufacturer11/05/2025
Initial Report FDA Received Date10/30/2025
Supplement Report FDA Received Date11/06/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured09/13/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
If action reported to FDA under 21 USC 360i(g), list
FDA-assigned Recall Number or include a statement
Z-2485-2025
Patient Sequence Number1
Patient Age70 YR
Patient SexMale
-
-